Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

834 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.
Castle PE, Pierz AJ, Adcock R, Aslam S, Basu PS, Belinson JL, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco EL, Gravitt PE, Isidean SD, Lin J, Mahmud SM, Monsonego J, Muwonge R, Ratnam S, Safaeian M, Schiffman M, Smith JS, Swarts A, Wright TC, Van De Wyngard V, Xi LF. Castle PE, et al. Among authors: ratnam s. Cancer Prev Res (Phila). 2020 Oct;13(10):829-840. doi: 10.1158/1940-6207.CAPR-20-0182. Epub 2020 Jul 12. Cancer Prev Res (Phila). 2020. PMID: 32655005
Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial.
Isidean SD, Mayrand MH, Ramanakumar AV, Gilbert L, Reid SL, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL; CCCaST Study Group. Isidean SD, et al. Among authors: ratnam s. Int J Cancer. 2016 Dec 1;139(11):2456-66. doi: 10.1002/ijc.30385. Epub 2016 Aug 30. Int J Cancer. 2016. PMID: 27538188 Free article. Clinical Trial.
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL; CCCaST Study Group. Mayrand MH, et al. Among authors: ratnam s. Int J Cancer. 2006 Aug 1;119(3):615-23. doi: 10.1002/ijc.21897. Int J Cancer. 2006. PMID: 16572425 Free article. Clinical Trial.
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL; Canadian Cervical Cancer Screening Trial Study Group. Mayrand MH, et al. Among authors: ratnam s. N Engl J Med. 2007 Oct 18;357(16):1579-88. doi: 10.1056/NEJMoa071430. N Engl J Med. 2007. PMID: 17942871 Free article. Clinical Trial.
HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
Richardson LA, El-Zein M, Ramanakumar AV, Ratnam S, Sangwa-Lugoma G, Longatto-Filho A, Cardoso MA, Coutlée F, Franco EL; PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium. Richardson LA, et al. Among authors: ratnam s. Cancer Cytopathol. 2015 Dec;123(12):745-54. doi: 10.1002/cncy.21596. Epub 2015 Jul 31. Cancer Cytopathol. 2015. PMID: 26230283 Free article.
834 results